Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Physical Exam
1.2.3 Laboratory Tests
1.2.4 Imaging Tests
1.2.5 Gleason Score
1.2.6 TNM Score
1.2.7 Genetic Tests
1.2.8 Digital Rectal Exam
1.2.9 Biopsy
1.3 Market by Application
1.3.1 Global Prostate Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.3.5 Cancer Institutes
1.3.6 Diagnostic Centers
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Screening Market Perspective (2018-2033)
2.2 Prostate Cancer Screening Growth Trends by Region
2.2.1 Global Prostate Cancer Screening Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Prostate Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Screening Forecasted Market Size by Region (2024-2033)
2.3 Prostate Cancer Screening Market Dynamics
2.3.1 Prostate Cancer Screening Industry Trends
2.3.2 Prostate Cancer Screening Market Drivers
2.3.3 Prostate Cancer Screening Market Challenges
2.3.4 Prostate Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Screening Players by Revenue
3.1.1 Global Top Prostate Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Screening Revenue
3.4 Global Prostate Cancer Screening Market Concentration Ratio
3.4.1 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Screening Revenue in 2022
3.5 Prostate Cancer Screening Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Screening Product Solution and Service
3.7 Date of Enter into Prostate Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Screening Breakdown Data by Type
4.1 Global Prostate Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2024-2033)
5 Prostate Cancer Screening Breakdown Data by Application
5.1 Global Prostate Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Prostate Cancer Screening Market Size (2018-2033)
6.2 North America Prostate Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Prostate Cancer Screening Market Size by Country (2018-2023)
6.4 North America Prostate Cancer Screening Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Screening Market Size (2018-2033)
7.2 Europe Prostate Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Prostate Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Prostate Cancer Screening Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Screening Market Size (2018-2033)
8.2 Asia-Pacific Prostate Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Prostate Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate Cancer Screening Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Screening Market Size (2018-2033)
9.2 Latin America Prostate Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Prostate Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Prostate Cancer Screening Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Screening Market Size (2018-2033)
10.2 Middle East & Africa Prostate Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Prostate Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate Cancer Screening Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Prostate Cancer Screening Introduction
11.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Almac
11.2.1 Almac Company Detail
11.2.2 Almac Business Overview
11.2.3 Almac Prostate Cancer Screening Introduction
11.2.4 Almac Revenue in Prostate Cancer Screening Business (2018-2023)
11.2.5 Almac Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Prostate Cancer Screening Introduction
11.3.4 Bayer Revenue in Prostate Cancer Screening Business (2018-2023)
11.3.5 Bayer Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Screening Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business (2018-2023)
11.4.5 Beckman Coulter Recent Development
11.5 BioméRieux
11.5.1 BioméRieux Company Detail
11.5.2 BioméRieux Business Overview
11.5.3 BioméRieux Prostate Cancer Screening Introduction
11.5.4 BioméRieux Revenue in Prostate Cancer Screening Business (2018-2023)
11.5.5 BioméRieux Recent Development
11.6 Genomic Health
11.6.1 Genomic Health Company Detail
11.6.2 Genomic Health Business Overview
11.6.3 Genomic Health Prostate Cancer Screening Introduction
11.6.4 Genomic Health Revenue in Prostate Cancer Screening Business (2018-2023)
11.6.5 Genomic Health Recent Development
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Detail
11.7.2 Mayo Clinic Business Overview
11.7.3 Mayo Clinic Prostate Cancer Screening Introduction
11.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business (2018-2023)
11.7.5 Mayo Clinic Recent Development
11.8 Mdxhealth
11.8.1 Mdxhealth Company Detail
11.8.2 Mdxhealth Business Overview
11.8.3 Mdxhealth Prostate Cancer Screening Introduction
11.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business (2018-2023)
11.8.5 Mdxhealth Recent Development
11.9 Roche Diagnostics
11.9.1 Roche Diagnostics Company Detail
11.9.2 Roche Diagnostics Business Overview
11.9.3 Roche Diagnostics Prostate Cancer Screening Introduction
11.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business (2018-2023)
11.9.5 Roche Diagnostics Recent Development
11.10 Rosetta Genomics
11.10.1 Rosetta Genomics Company Detail
11.10.2 Rosetta Genomics Business Overview
11.10.3 Rosetta Genomics Prostate Cancer Screening Introduction
11.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business (2018-2023)
11.10.5 Rosetta Genomics Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Detail
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Prostate Cancer Screening Introduction
11.11.4 Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2018-2023)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Hologic
11.12.1 Hologic Company Detail
11.12.2 Hologic Business Overview
11.12.3 Hologic Prostate Cancer Screening Introduction
11.12.4 Hologic Revenue in Prostate Cancer Screening Business (2018-2023)
11.12.5 Hologic Recent Development
11.13 Myriad Genetics
11.13.1 Myriad Genetics Company Detail
11.13.2 Myriad Genetics Business Overview
11.13.3 Myriad Genetics Prostate Cancer Screening Introduction
11.13.4 Myriad Genetics Revenue in Prostate Cancer Screening Business (2018-2023)
11.13.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prostate Cancer Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Physical Exam
Table 3. Key Players of Laboratory Tests
Table 4. Key Players of Imaging Tests
Table 5. Key Players of Gleason Score
Table 6. Key Players of TNM Score
Table 7. Key Players of Genetic Tests
Table 8. Key Players of Digital Rectal Exam
Table 9. Key Players of Biopsy
Table 10. Global Prostate Cancer Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Prostate Cancer Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Prostate Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Prostate Cancer Screening Market Share by Region (2018-2023)
Table 14. Global Prostate Cancer Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Prostate Cancer Screening Market Share by Region (2024-2033)
Table 16. Prostate Cancer Screening Market Trends
Table 17. Prostate Cancer Screening Market Drivers
Table 18. Prostate Cancer Screening Market Challenges
Table 19. Prostate Cancer Screening Market Restraints
Table 20. Global Prostate Cancer Screening Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Prostate Cancer Screening Market Share by Players (2018-2023)
Table 22. Global Top Prostate Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Screening as of 2022)
Table 23. Ranking of Global Top Prostate Cancer Screening Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Prostate Cancer Screening Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Prostate Cancer Screening Product Solution and Service
Table 27. Date of Enter into Prostate Cancer Screening Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Prostate Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Prostate Cancer Screening Revenue Market Share by Type (2018-2023)
Table 31. Global Prostate Cancer Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Prostate Cancer Screening Revenue Market Share by Type (2024-2033)
Table 33. Global Prostate Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Prostate Cancer Screening Revenue Market Share by Application (2018-2023)
Table 35. Global Prostate Cancer Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Prostate Cancer Screening Revenue Market Share by Application (2024-2033)
Table 37. North America Prostate Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Prostate Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Prostate Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Prostate Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe Prostate Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Prostate Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific Prostate Cancer Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific Prostate Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Prostate Cancer Screening Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America Prostate Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America Prostate Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Prostate Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa Prostate Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa Prostate Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Prostate Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 52. Abbott Laboratories Company Detail
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Prostate Cancer Screening Product
Table 55. Abbott Laboratories Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Almac Company Detail
Table 58. Almac Business Overview
Table 59. Almac Prostate Cancer Screening Product
Table 60. Almac Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 61. Almac Recent Development
Table 62. Bayer Company Detail
Table 63. Bayer Business Overview
Table 64. Bayer Prostate Cancer Screening Product
Table 65. Bayer Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Beckman Coulter Company Detail
Table 68. Beckman Coulter Business Overview
Table 69. Beckman Coulter Prostate Cancer Screening Product
Table 70. Beckman Coulter Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 71. Beckman Coulter Recent Development
Table 72. BioméRieux Company Detail
Table 73. BioméRieux Business Overview
Table 74. BioméRieux Prostate Cancer Screening Product
Table 75. BioméRieux Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 76. BioméRieux Recent Development
Table 77. Genomic Health Company Detail
Table 78. Genomic Health Business Overview
Table 79. Genomic Health Prostate Cancer Screening Product
Table 80. Genomic Health Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 81. Genomic Health Recent Development
Table 82. Mayo Clinic Company Detail
Table 83. Mayo Clinic Business Overview
Table 84. Mayo Clinic Prostate Cancer Screening Product
Table 85. Mayo Clinic Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 86. Mayo Clinic Recent Development
Table 87. Mdxhealth Company Detail
Table 88. Mdxhealth Business Overview
Table 89. Mdxhealth Prostate Cancer Screening Product
Table 90. Mdxhealth Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 91. Mdxhealth Recent Development
Table 92. Roche Diagnostics Company Detail
Table 93. Roche Diagnostics Business Overview
Table 94. Roche Diagnostics Prostate Cancer Screening Product
Table 95. Roche Diagnostics Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 96. Roche Diagnostics Recent Development
Table 97. Rosetta Genomics Company Detail
Table 98. Rosetta Genomics Business Overview
Table 99. Rosetta Genomics Prostate Cancer Screening Product
Table 100. Rosetta Genomics Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 101. Rosetta Genomics Recent Development
Table 102. Thermo Fisher Scientific Company Detail
Table 103. Thermo Fisher Scientific Business Overview
Table 104. Thermo Fisher Scientific Prostate Cancer Screening Product
Table 105. Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 106. Thermo Fisher Scientific Recent Development
Table 107. Hologic Company Detail
Table 108. Hologic Business Overview
Table 109. Hologic Prostate Cancer Screening Product
Table 110. Hologic Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 111. Hologic Recent Development
Table 112. Myriad Genetics Company Detail
Table 113. Myriad Genetics Business Overview
Table 114. Myriad Genetics Prostate Cancer Screening Product
Table 115. Myriad Genetics Revenue in Prostate Cancer Screening Business (2018-2023) & (US$ Million)
Table 116. Myriad Genetics Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Screening Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Prostate Cancer Screening Market Share by Type: 2022 VS 2033
Figure 3. Physical Exam Features
Figure 4. Laboratory Tests Features
Figure 5. Imaging Tests Features
Figure 6. Gleason Score Features
Figure 7. TNM Score Features
Figure 8. Genetic Tests Features
Figure 9. Digital Rectal Exam Features
Figure 10. Biopsy Features
Figure 11. Global Prostate Cancer Screening Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global Prostate Cancer Screening Market Share by Application: 2022 VS 2033
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Research Labs Case Studies
Figure 16. Cancer Institutes Case Studies
Figure 17. Diagnostic Centers Case Studies
Figure 18. Others Case Studies
Figure 19. Prostate Cancer Screening Report Years Considered
Figure 20. Global Prostate Cancer Screening Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 21. Global Prostate Cancer Screening Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 22. Global Prostate Cancer Screening Market Share by Region: 2022 VS 2033
Figure 23. Global Prostate Cancer Screening Market Share by Players in 2022
Figure 24. Global Top Prostate Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Screening as of 2022)
Figure 25. The Top 10 and 5 Players Market Share by Prostate Cancer Screening Revenue in 2022
Figure 26. North America Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. North America Prostate Cancer Screening Market Share by Country (2018-2033)
Figure 28. United States Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Canada Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Europe Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Prostate Cancer Screening Market Share by Country (2018-2033)
Figure 32. Germany Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Asia-Pacific Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Prostate Cancer Screening Market Share by Region (2018-2033)
Figure 40. China Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Japan Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Latin America Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Latin America Prostate Cancer Screening Market Share by Country (2018-2033)
Figure 48. Mexico Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Brazil Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Prostate Cancer Screening Market Share by Country (2018-2033)
Figure 52. Turkey Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Prostate Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 55. Almac Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 56. Bayer Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 57. Beckman Coulter Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 58. BioméRieux Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 59. Genomic Health Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 60. Mayo Clinic Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 61. Mdxhealth Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 62. Roche Diagnostics Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 63. Rosetta Genomics Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 65. Hologic Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 66. Myriad Genetics Revenue Growth Rate in Prostate Cancer Screening Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed